The pandemic has caused a shift in how drug firms are viewed: their capacity for big-money innovation will give them immunity in the crisis. Widespread homeworking will have broad consequences, from commercial-property values to urban demographics. And a seemingly innocuous Hong Kong history exam is a window into the territory’s increasingly fraught politics.
For full access to print, digital and audio editions of The Economist, subscribe here www.economist.com/radiooffer
See acast.com/privacy for privacy and opt-out information.
📆 2020-05-25 17:30 / ⌛ 00:25:01
📆 2020-05-25 12:00 / ⌛ 00:22:16
📆 2020-05-25 01:00 / ⌛ 00:22:29
📆 2020-05-22 19:14 / ⌛ 00:37:53
📆 2020-05-22 12:12 / ⌛ 00:23:06